Advertisement

Springer Seminars in Immunopathology

, Volume 21, Issue 2, pp 191–197 | Cite as

Gene therapy in the treatment of ocular inflammation

  • Karl Csaky
  • Robert Nussenblatt
Article

Abstract

Gene therapy may become a powerful therapeutic modality in the treatment of both ocular inflammatory disease and as a means of preventing rejection following tissue transplantation. By directly introducing into ocular cells genes that encode proteins capable of down-regulating the immune response, gene therapy has potential for both therapy and as a method for studying mechanisms of disease. While marked and rapid advances in the study of gene therapy have been realized, technical questions regarding the appropriate vector or the choice of efficacious immunomodulatory protein still remain.

Keywords

Immune Response Internal Medicine Gene Therapy Inflammatory Disease Cell Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Algvere PV, et al (1994) Transplantation of fetal retinal pigment epithelium in age-related macular degeneration with subfoveal neovascularization. Graefes Arch Clin Exp Ophthalmol 232:707Google Scholar
  2. 2.
    Allison J, et al (1997) Transgenic expression of CD95 ligand on islet beta cells induces a granulocytic infiltration but does not confer immune privilege upon islet allografts. Proc Natl Acad Sci USA 94:3943Google Scholar
  3. 3.
    Anglade E, Csaky KG (1998) Recombinant adenovirus-mediated gene transfer into the adult rat retina. Curr Eye Res 17:316Google Scholar
  4. 4.
    Bandara G, et al (1993) Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci USA 90:10764Google Scholar
  5. 5.
    Blau HM, Springer ML (1995) Gene therapy — a novel form of drug delivery. N Engl J Med 333:1204Google Scholar
  6. 6.
    Caspi RR, et al (1988) A new model of autoimmune disease. Experimental autoimmune uveoretinitis induced in mice with two different retinal antigens. J Immunol 140:1490Google Scholar
  7. 7.
    Chen LZ, et al (1998) Gene therapy in allergic encephalomyelitis using myelin basic protein-specific T cells engineered to express latent transforming growth factor-betal. Proc Natl Acad Sci USA 95:12516Google Scholar
  8. 8.
    Cornetta K, Morgan RA, Anderson WF (1991) Safety issues related to retroviral-mediated gene transfer in humans. Hum Gene Ther 2:5Google Scholar
  9. 9.
    Daheshia M, et al (1997) Suppression of ongoing ocular inflammatory disease by topical administration of plasmid DNA encoding IL-10. J Immunol 159:1945Google Scholar
  10. 10.
    Engelhardt JF, et al (1994) Ablation of E2A in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 91:6196Google Scholar
  11. 11.
    Flannery JG, et al (1997) Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc Natl Acad Sci USA 94:6916Google Scholar
  12. 12.
    Gossen M, et al (1995) Transcriptional activation by tetracyclines in mammalian cells. Science 268:1766Google Scholar
  13. 13.
    Griffith TS, et al (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270:1189Google Scholar
  14. 14.
    Hangai M, et al (1996) In vivo gene transfer into the retina mediated by a novel liposome system. Invest Ophthalmol Vis Sci 37:2678Google Scholar
  15. 15.
    Kimura H, et al (1996) Retrovirus-mediated suicide gene transduction in the vitreous cavity of the eye: feasibility in prevention of proliferate vitreoretinopathy. Hum Gene Ther 7:799Google Scholar
  16. 16.
    Lanzavecchia A (1993) Identifying strategies for immune intervention. Science 260:937Google Scholar
  17. 17.
    Lenschow DJ, et al (1992) Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA41g. Science 257:789Google Scholar
  18. 18.
    Ma Y, et al (1998) Inhibition of collagen-induced arthritis in mice by viral IL-10 gene transfer. J lmmunol 161:1516Google Scholar
  19. 19.
    Mathisen PM, et al (1997) Treatment of experimental autoimmune encephalomyelitis with genetically modified memory T cells. J Exp Med 186:159Google Scholar
  20. 20.
    Miyoshi H, et al (1997) Stable and efficient gene transfer into the retina using an HIV based lentiviral vector. Proc Natl Acad Sci USA 94:10319Google Scholar
  21. 21.
    Mulligan RC (1993) The basic science of gene therapy. Science 260:926Google Scholar
  22. 22.
    Neurath ME, et al (1996) Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice. Nat Med 2:998Google Scholar
  23. 23.
    Nussenblatt RB (1997) Uveitis in Behcet's disease. Int Rev Immunol 14:67Google Scholar
  24. 24.
    Nussenblatt RB, Csaky K (1997) Perspectives on gene therapy in the treatment of ocular inflammation. Eye 11:217Google Scholar
  25. 25.
    Papavassiliou AG (1995) Molecular medicine. Transcription factors. N Engl J Med 332:45Google Scholar
  26. 26.
    Qin L, Ding Y, Bromberg JS (1996) Gene transfer of transforming growth factor-beta 1 prolongs murine cardiac allograft survival by inhibiting cell-mediated immunity. Hum Gene Ther 7:1981Google Scholar
  27. 27.
    Raz E, et al (1995) Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery. Lupus 4:286Google Scholar
  28. 28.
    Tombran-Tink J, Chader GG, Johnson LV (1991) PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity [letter]. Exp Eye Res 53:411Google Scholar
  29. 29.
    Unoki K, LaVail MM (1994) Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest Ophthalmol Vis Sci 35:907Google Scholar
  30. 30.
    Wells DJ (1995) Intramuscular injection of plasmid DNA. Mot Cell Biol Hum Dis Ser 5:83Google Scholar
  31. 31.
    Whitcup SM, et al (1992) Endothelial leukocyte adhesion molecule-1 in endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 33:2626Google Scholar
  32. 32.
    Whitcup SM, et al (1993) Monoclonal antibody against CD11b/CD18 inhibits endotoxin-induced uveitis. Invest Ophthalmol Vis Sci 34:673Google Scholar
  33. 33.
    Whittington HA, Ashworth LJ, Hawkins RE (1998) Recombinant adenoviral delivery for in vivo expression of scFv antibody fusion proteins. Gene Ther 5:770Google Scholar
  34. 34.
    Wilson JM (1996) Adenoviruses as gene-delivery vehicles. N Engl J Med 334:1185Google Scholar
  35. 35.
    Wrighton CJ, et al (1996) Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B. J Exp Med 183:1013Google Scholar
  36. 36.
    Zhang X, Bok D (1998) Transplantation of retinal pigment epithelial cells and immune response in the subretinal space. Invest Ophthalmol Vis Sci 39:1021Google Scholar

Copyright information

© Springer-Verlag 1999

Authors and Affiliations

  • Karl Csaky
    • 1
  • Robert Nussenblatt
    • 1
  1. 1.National Eye InstituteBethesdaUSA

Personalised recommendations